Skip to main content
. Author manuscript; available in PMC: 2022 Jun 15.
Published in final edited form as: Circ Heart Fail. 2021 Jun 15;14(6):e007909. doi: 10.1161/CIRCHEARTFAILURE.120.007909

Figure 1:

Figure 1:

Comparison of renal function assessment using serum Cystatin C- and serum Creatinine-eGFR among Heart Failure, LVAD and Heart Transplant patients.

p-value: * 0.05–0.001; ** 0.001–0.0001; *** <0.0001; all comparisons denoted with any * had a false discovery rate <0.05. HF, heart failure; HT, heart transplant, LVAD, left ventricular assist device.